Time and Distance Cost of Longer Acting Anti-VEGF Therapies for Macular Degeneration: Contributions to Drug Cost Comparisons

PURPOSE: To evaluate the holistic cost of longer acting anti-VEGF therapy for macular degeneration when considering the associated costs of travel to the retina clinic. DESIGN: Theoretical evaluation of cost using publicly available pricing data and reimbursements at the Veterans Affairs (VA) Medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Meer, Elana A, Oh, Dennis H, Brodie, Frank L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792116/
https://www.ncbi.nlm.nih.gov/pubmed/36578665
http://dx.doi.org/10.2147/OPTH.S384995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792116/
https://www.ncbi.nlm.nih.gov/pubmed/36578665
http://dx.doi.org/10.2147/OPTH.S384995

Ejemplares similares